Larvol Delta - In-AIS-with-inadequate-response-to-tenecteplase-tirofiban-vs-placebo-increased-excellent-functional-outcome-rate-at-90-d

TNKASE (tenecteplase) - Roche, Boehringer Ingelheim

Aggrastat (tirofiban) - Correvio, Medicure

http://www.ncbi.nlm.nih.gov/pubmed/42673593

; Michael D Hill; Zaid AlSaaran

Sep 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next